©2025 Stanford Medicine
Neonatal Seizure Registry - Developmental Functional EValuation
Not Recruiting
Trial ID: NCT04337697
Purpose
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.
Official Title
Neonatal Seizure Registry - Developmental Functional EValuation
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
* Enrolled in NSR-II
* Alive at the start of the NSR-DEV study period
* Parent(s) who are English or Spanish literate (with assistance of interpreter)
Exclusion Criteria:
* Neonates who were found to have exclusion criteria after NSR-II enrollment
* Risk for adverse outcome independent of seizures and underlying brain injury (including but not limited to: inborn errors of metabolism, fetal infection, brain malformation)
* Transient cause for seizures (e.g., mild hypoglycemia, hyponatremia, hypocalcemia with normal neuroimaging)
* Neonatal-onset epilepsy syndromes
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Courtney J. Wusthoff, MD
650-723-0993